APR (278470) Q3 2026 earnings summary

Executive summary

• 3Q26 revenue reached a quarterly record of KRW 773.1bn, up 100.3% YoY; operating profit rose 68.9% to KRW 160.6bn.

• Record cosmetics revenue and overseas growth drove results; stronger KRW weighed on translated revenue and profitability.

Financial highlights

• 3Q26 net profit was KRW 110.2bn, up 47.6% YoY.

• 9M26 revenue was KRW 2,134.0bn, operating profit KRW 503.5bn and net profit KRW 369.0bn.

• At Sep. 30, 2026, total assets were KRW 1,268.9bn, liabilities KRW 604.9bn and equity KRW 664.0bn.

• Q3 included KRW 10bn of tariff refunds; remaining refunds were estimated at KRW 10bn or less, with possible additional refunds as products sell.

Outlook and guidance

• Full-year revenue guidance remains KRW 3T, with management seeking to exceed it; the operating profit objective is KRW 730B–750B, while Q4 margin delivery remains uncertain amid FX pressure.

• 2027 plans are described as aggressive, with high revenue and operating profit growth expected; formal guidance is planned with Q4 results.

• October Amazon promotions produced record daily U.S. and major European sales; 13 medicube products ranked in Amazon U.S. Beauty Top 100, and Italy had 8 of the top 11 beauty products.

• HIFU-based EBD launch is planned by year-end 2026; a high-frequency EBD product is expected in mid-to-late 2027, subject to medical certification.